Evaluating Two Multifocal Daily Disposable Contact Lenses
NCT ID: NCT05579886
Last Updated: 2024-02-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-10-10
2023-02-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses
NCT05763628
Evaluation of the Performance of Different Daily Disposable Lens Designs in Habitual Soft Contact Lens Wearers
NCT04668989
Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses
NCT05805059
Clinical Evaluation of Two Multifocal Contact Lenses
NCT05457608
Multifocal Contact Lenses Fitting Methods Comparison
NCT05734846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Lens
All participants wore the Control Lens for 2 weeks (Period 1)
Control Lens
Daily disposable multifocal soft lens with 2 add design (2ADD) for 2 weeks
Test Lens
All participants wore the Test Lens for 2 weeks (Period 2)
Test Lens
Daily disposable multifocal soft lens with 3 add design (3ADD) for 2 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control Lens
Daily disposable multifocal soft lens with 2 add design (2ADD) for 2 weeks
Test Lens
Daily disposable multifocal soft lens with 3 add design (3ADD) for 2 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Was at least 42 years of age and had full legal capacity to volunteer;
2. Had read and signed an information consent letter;
3. Self-reported having had a full eye examination in the previous two years;
4. Anticipated being able to wear the study lenses for at least 8 hours a day, 5 days a week;
5. Was willing and able to follow instructions and maintain the appointment schedule;
6. Habitually wore multifocal soft contact lenses, for the past 3 months minimum (NOTE: the habitual contact lens type was restricted such that no more than one third were to be the clariti 1 day multifocal and no more than one third were to be MyDay multifocal (this included their equivalent private label brand name);
7. Had refractive astigmatism no higher than -0.75DC in each eye;
8. Was presbyopic and required a reading addition of at least +0.75D and no more than +2.50D in each eye;
9. Could be fit and achieved binocular distance vision of at least 20/30 Snellen (or +0.20 logMAR) which participants also deemed to be 'acceptable', with the available study lens parameters (powers +4.00 to -6.00DS)
Exclusion Criteria
1. Was participating in any concurrent clinical or research study;
2. Had any known active ocular disease and/or infection that contraindicated contact lens wear;
3. Had a systemic condition that in the opinion of the investigator may have affected a study outcome variable;
4. Was using any systemic or topical medications that in the opinion of the investigator may have affected contact lens wear or a study outcome variable;
5. Had known sensitivity to the diagnostic sodium fluorescein to be used in the study;
6. Self-reported as pregnant, lactating or planning a pregnancy at the time of enrolment;
7. Had undergone refractive error surgery or interocular surgery.
42 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre for Ocular Research & Education, Canada
OTHER
CooperVision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Sacco
Role: PRINCIPAL_INVESTIGATOR
Sacco Eye Group
Shane Kannarr
Role: PRINCIPAL_INVESTIGATOR
Kannarr Eye Care
Katherine Bickle
Role: PRINCIPAL_INVESTIGATOR
ProCare Vision Center
Michael Cymbor
Role: PRINCIPAL_INVESTIGATOR
Nittany Eye Associates
Roxanne Achong-Coan
Role: PRINCIPAL_INVESTIGATOR
Coan Eye Care & Optical Boutique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coan Eye Care & Optical Boutique
Ocoee, Florida, United States
Kannarr Eye Care
Pittsburg, Kansas, United States
Sacco Eye Group
Vestal, New York, United States
ProCare Vision Center
Granville, Ohio, United States
Nittany Eye Associates
State College, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-MKTG-140
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.